Series D funding round for Mammoth Biosciences raising $150M in September 2021
Series D funding round for Mammoth Biosciences raising $150M in September 2021
| Investor | Firm Type | Partner |
|---|
Redmile GroupLEAD | Hedge Fund | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$303.1M
Top Valuation
-
Mammoth Biosciences raised $150M in a Series D round.
The round was announced on 09/01/21.
The round was led by Redmile Group.